Senate Boost To US FDA Device Spending Falls Short of House's Bid

The Senate would provide US FDA’s device program with a slight 2.2% boost in 2019 spending, to $299.99m, under numbers approved by the Senate Appropriations Committee May 24. But device activities ultimately could see a lot more next fiscal year, as the House is seeking $368.24m.

Capitol House

More from Legislation

More from Policy & Regulation